Abstract
The antitumor effects of SM‐5887, a totally synthetic 9‐aminoanthracycline derivative, were evaluated in six murinc experimental tumor systems (P38S, Ehrlich carcinoma, sarcoma 180, Lewis lung carcinoma, B16 melanoma and colon 38) and nine human tumor‐nude mouse systems (one breast cancer, two lung cancers and six gastric cancers). Characteristically SM‐5887 showed excellent antitumor activities, superior to adriamycin (ADR), against human tumor xenografts, although its activities against murine experimental tumors were almost equal to those of ADR. When the human tumors were implanted sc in female athymic mice (BALB/c, nu/nu) and their volume reached 100‐ 300 mm3, SM‐5887 and ADR were injected iv. All nine human tumors tested showed statistically significant responses to SM‐5887, and 7 of them were strongly suppressed in their growth by SM‐5887 so that minimum T/C values were less than 30% at the maximum tolerated dose (MTD, 25 mg/kg) with a single iv injection. Compared with ADR, SM‐5887 was statistically more effective in five tumors (one breast, one lung and three gastric), equal in two tumors (two gastric), and less potent in two tumors (one lung and one gastric). In addition, the 10‐day‐interval repeated iv treatments with SM‐5887 at the MTD (25 mg/kg) resulted in remarkably potent antitumor effects (including complete regression) against human gastric cancer, 4‐1ST, implanted in nude mice without enhancement of toxic effects, SM‐5887 was also effective against ip‐inoculated P388 by oral administration as well as iv injection.
Keywords: Anthracycline, SM‐5887, Antitumor activity
Full Text
The Full Text of this article is available as a PDF (364.0 KB).
REFERENCES
- 1. ) Arcamone , F. , Penco , S. , Vigevani , A. , Redaelli , S. , Franchi , G. , Di Marco , A. , Casazza , A. M. , Dasdia , T. , Formelli , F. , Necco , A. and Soranzo , C.Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone . J. Med, Chem. , 18 , 703 – 707 ( 1975. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Arcamone , F. , Bernardi , L. , Giardino , P. , Patelli , B. , Di Marco , A. , Casazza , A. M. , Pratesi , G. and Reggiani , P.Synthesis and antitumor activity of 4‐demethoxydauno‐rubicin, 4‐demethoxy‐7,9‐diepidaunorubicin, and their β anomers . Cancer Treat. Rep. , 60 , 829 – 834 ( 1976. ). [PubMed] [Google Scholar]
- 3. ) Oki , T. , Matsuzawa , Y. , Yoshimoto , A. , Numata , K. , Kitamura , I , Hori , S. , Takamatsu , A. , Umezawa , H. , Ishizuka , M. , Naganawa , H. , Suda , H. , Hamada , M , and Takeuchi , T.New antitumor antibiotics, aclacinomycin A and B . J. Antibiot. , 28 , 830 – 834 ( 1975. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Umezawa , H. , Takahashi , Y. , Kinoshita , M. , Naganawa , H. , Masuda , T. , Ishizuka , M. , Tatsuta , K. and Takeuchi , T.Tetrahydropyranyl derivatives of daunomycin and adriamycin . J. Antibiot. , 32 , 1082 – 1084 ( 1979. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Weiss , R. B. , Sarosy , G. , Clagett‐Carr , K. , Russo , M. and Leyland‐Jones , B.Anthracycline analogs: the past, present, and future . Cancer Chemother. Pharmacol. , 18 , 185 – 197 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Arcamone , F.Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture . Cancer Res. , 45 , 5995 – 5999 ( 1985. ). [PubMed] [Google Scholar]
- 7. ) Ishizumi , K. , Ohashi , N. and Tanno , N.Stereospecific total synthesis of 9‐aminoanthracyclines: (+)‐9‐amino‐9‐deoxydaunomycin and related compounds . J. Org. Chem. , 52 , 4477 – 4485 ( 1987. ). [Google Scholar]
- 8. ) Inaba , M. , Tashiro , T. , Kobayashi , T. , Fujimoto , S. , Sakurai , Y. , Maruo , K. , Ohnishi , Y. , Ueyama , Y , and Nomura , T.Evaluation of response rates to various anti‐tumor agents of human gastric tumors implanted in nude mouse . Jpn. J. Cancer Res. 77 , 190 – 196 ( 1986. ). [PubMed] [Google Scholar]
- 9. ) Giuliani , F. C. , Zirvi , K. A. and Kaplan , N. O.Therapeutic response of human tumor xenografts in athymic mice to doxorubicin . Cancer Res. , 41 , 325 – 335 ( 1981. ). [PubMed] [Google Scholar]
- 10. ) Barbieri , B. , Suarato , A. , Penco , S. , Geroni , C. , Bellini , O. , Fumagalli , A. , Casazza , A. M. and Giuliani , F.C.Biologic activity of 4′‐halo anthracyclines . Am. Assoc. Cancer Res. , 25 , 305 ( 1984. ). [Google Scholar]
- 11. ) Di Marco , A. , Casazza , A. M. and Pratesi , G.Antitumor activity of 4‐demethoxydaunorubicin administered orally . Cancer Treat. Rep. , 61 , 893 – 894 ( 1977. ). [PubMed] [Google Scholar]
- 12. ) Hori , S. , Shirai , M. , Hirano , S. , Oki , T. , Inui , T. , Tsukagoshi , S. , Ishizuka , M. , Takeuchi , T. and Umezawa , H.Antitumor activity of new anthracycline antibiotics, aclacinomycin‐A and its analogs, and their toxicity . Gann , 68 , 685 – 690 ( 1977. ). [PubMed] [Google Scholar]